Wolverine Trading
TRIB

Wolverine Trading’s Trinity Biotech TRIB Stock Holding History

Wolverine Trading’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-2,620
Closed -$73K – 5491
2017
Q3 		$73K Buy
+2,620
New +$73.1K ﹤0.01% 4157
2017
Q2 		– Sell
-3,100
Closed -$93K – 4972
2017
Q1 		$93K Sell
3,100
-1,320
-30% -$41.3K ﹤0.01% 3844
2016
Q4 		$153K Buy
+4,420
New +$152K ﹤0.01% 3902

Other funds holding TRIB

HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $756M AUM 19.99% 1-Year Est. Return
SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
WCM
Whitefort Capital Management New York $339M AUM 52.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Wolverine Trading's TRIB Position: Q2 2021 in Review

Wolverine Trading sold out of Trinity Biotech (TRIB) in Q2 2021, closing a stake of 2,002 shares — an estimated $40K sold.

Wolverine Trading first reported a position in TRIB in Q4 2016 and held it in 2 quarters. The position peaked at $76K in Q4 2016. 29 funds tracked by Wall St. Rank hold TRIB as of Q2 2021.

  • Wolverine Trading reported no remaining Trinity Biotech position as of Q2 2021 after selling out during the quarter.
  • Wolverine Trading sold 2,002 Trinity Biotech shares in Q2 2021, an estimated $40K.
  • Wolverine Trading first reported a position in Trinity Biotech in Q4 2016 and held it in 2 quarters.
  • Wolverine Trading's Trinity Biotech position peaked at $76K in Q4 2016.
  • 29 funds tracked by Wall St. Rank held Trinity Biotech as of Q2 2021.

Based on Wolverine Trading's 13F filing for Q2 2021, filed 6 Aug 2021.